Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BID .1275 x ask .1280

I think I agree with you, though perhaps a bit differently.

For starters, last quarter included only 1 license - Asustek. Also Asustek paid an EXTREMELY PALTRY $290K fee prior to German revalidation and '584 revalidation, and '336 Final Rejection but also examiner interview to prepare response action. When we consider these other companies that have signed all after the German decision, a few before the '584 and '336 actions, and a couple after, if the next quarterly shows MMP revenues returning to prior levels, ie for this quarter would mean in the $6M range to PDS, probably $2.5M to PTSC, AND if Crossflo shows some traction this quarter, with continued revenue projections in the $3M to $6M for the calendar year, then PTSC may indeed be turning a bit of a corner on the pps. However, if the PDS shows license fees in this quarter of $1M or so for the 5 that have signed, then we better hope the Crossflo PR machine starts humming with contract announcements, as at least that will provide a projectable and measurable revenue stream for RG to talk about. Usually, that's what the market wants, and even if at a much smaller scale than the MMP revs of past, hopefully the predicatability of it will make the difference.



On an aside note, it's interesting that Flowers specifically mentioned that he did NOT expect that PTSC would need to fund PDS further. With the money already agreed due to TPL from PDS for the patent lobbying efforts, and the limited PDS bankroll coming out of last quarter, it suggests that Flowers KNEW about these already announced licenses that have happened since the CC, and that they actually may be of a better fee structure than Asustek was since they would cover the funding requirements, by implication. I haven't really studied it specifically, but intuitively, it seems that we can find some insight be reviewing what was said, the PDS funding requirements, and what has been signed this quarter. Maybe when I take a break from admiring the UNPRECEDENTED Lombardi No. SIX, and the BEST QB IN THE HISTORY OF THE NFL OVER HIS FIRST FIVE SEASONS, I'll have a second to look into it in more detail.

Share
New Message
Please login to post a reply